Literature DB >> 1891282

Prostaglandin inhibition prevents the fall in pulmonary vascular resistance as a result of rhythmic distension of the lungs in fetal lambs.

H Velvis1, P Moore, M A Heymann.   

Abstract

Prostaglandins (PG) are vasoactive factors involved in the regulation of pulmonary vascular resistance at birth. However, their physiologic importance is unclear. We hypothesized that PG are important regulators of pulmonary vascular resistance during static and rhythmic distension of the lungs. To test this hypothesis, we studied seven near-term fetal lambs treated with meclofenamate (a PG synthetase inhibitor) and six controls. The fetal lambs were instrumented on a long-term basis with vascular catheters to measure pulmonary arterial pressures, left atrial pressures, and pulmonary blood flow (radionuclide-labeled microsphere method). The fetal airway was intubated, and the ductus arteriosus wall was infiltrated with formalin to assure full patency during the study period. Pulmonary vascular resistance was calculated during baseline and during sequential in utero static distension of the fetal lungs, rhythmic distension, and ventilation with oxygenation. We found that during rhythmic distension, inhibition of PG synthesis abolished the 4-fold decrease in pulmonary vascular resistance seen in the control group. In contrast, during static distension, pulmonary vascular resistance did not change in either group, and during ventilation with oxygenation, pulmonary vascular resistance decreased 12-fold in both groups. We conclude that PG are important regulators of pulmonary vascular resistance during rhythmic distension but are not essential for the regulation of pulmonary vascular resistance during static distension or during ventilation with oxygenation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1891282     DOI: 10.1203/00006450-199107000-00013

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  8 in total

1.  Pulmonary hemodynamic responses to in utero ventilation in very immature fetal sheep.

Authors:  Beth J Allison; Kelly J Crossley; Sharon J Flecknoe; Colin J Morley; Graeme R Polglase; Stuart B Hooper
Journal:  Respir Res       Date:  2010-08-19

2.  Chronic nitric oxide inhibition in utero produces persistent pulmonary hypertension in newborn lambs.

Authors:  J R Fineman; J Wong; F C Morin; L M Wild; S J Soifer
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

Review 3.  Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn.

Authors:  Batoule H Majed; Raouf A Khalil
Journal:  Pharmacol Rev       Date:  2012-06-07       Impact factor: 25.468

Review 4.  Advances in the diagnosis and management of persistent pulmonary hypertension of the newborn.

Authors:  G Ganesh Konduri; U Olivia Kim
Journal:  Pediatr Clin North Am       Date:  2009-06       Impact factor: 3.278

Review 5.  Pulmonary Hypertension: The Hidden Danger for Newborns.

Authors:  Steven H Abman
Journal:  Neonatology       Date:  2021-05-05       Impact factor: 4.035

Review 6.  Modulation of pulmonary vasomotor tone in the fetus and neonate.

Authors:  N S Ghanayem; J B Gordon
Journal:  Respir Res       Date:  2001-03-08

7.  Altered prostanoid metabolism contributes to impaired angiogenesis in persistent pulmonary hypertension in a fetal lamb model.

Authors:  Chaitali N Mahajan; Adeleye J Afolayan; Annie Eis; Ru-Jeng Teng; Girija G Konduri
Journal:  Pediatr Res       Date:  2014-12-18       Impact factor: 3.756

8.  Vasodilator effects of dehydroepiandrosterone (DHEA) on fetal pulmonary circulation: An experimental study in pregnant sheep.

Authors:  Dyuti Sharma; Hélène Coridon; Estelle Aubry; Ali Houeijeh; Véronique Houfflin-Debarge; Rémi Besson; Philippe Deruelle; Laurent Storme
Journal:  PLoS One       Date:  2018-06-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.